Solid-Phase Synthesis of Deoxynucleic Guanidine (DNG) Oligomers and Melting Point and Circular Dichroism Analysis of Binding Fidelity of Octameric Thymidyl Oligomers with DNA Oligomers
Abstract:A practical solid-phase synthesis of deoxynucleic guanidine (DNG), a positively charged DNA backbone analogue, is reported. The nucleoside coupling step in the solid-phase synthesis of DNG involves the attack of a terminal 3′-amine upon an electronically activated 5′-carbodiimide to create a protected guanidinium internucleoside linkage. The activated carbodiimide is synthesized in situ by the mercury(II) abstraction of sulfur from an unsymmetrically substituted thiourea in which one substituent is an electron… Show more
“…Kinetic studies have also revealed that the rate of triple helix formation between DNG (T 5 ) with short oligodeoxyadenylates, is an order of magnitude faster than the formation of DNA triplexes at similar salt concentrations [146]. Also, investigations with DNG (T 5 and T 8 ), show that T m 's are significantly reduced by base pair mismatches [147,148]. This suggest that sequence specific base pairing is the predominant mode of binding between DNG and nucleic acid targets, although it has still to be established whether or not this is accompanied by any non-specific binding, via salt bridges, between the oppositely charged backbones.…”
“…Such studies appear close at hand with the development of an efficient solid phase synthetic method for the synthesis of DNG (Fig. 18) [148]. The synthesis involves the coupling of a 3´-amino nucleoside 58, immobilised on a polystyrene resin, with a 5´-carbodiimide intermediate which is derived from the thiourea 59, upon treatment with HgCl 2 .…”
Nucleic acids have been extensively modified by replacing the phosphodiester group or the whole sugar phosphodiester with alternative anionic, neutral and cationic structures. Several of these modified oligonucleotides exhibit improved properties including enhanced recognition and binding to RNA, duplex DNA and proteins. This has resulted in the development of new and more potent antisense and antigene agents, as well as aptamers. Furthermore, backbone modified oligonucleotides have also been used in the development of several alternative strategies, which rely on altogether different mechanisms of action and show significant promise for therapeutic intervention. In this review the latest advances in the synthesis and evaluation of the most promising backbone modified oligos will be discussed, with a view to their future as novel pharmaceuticals.
“…Kinetic studies have also revealed that the rate of triple helix formation between DNG (T 5 ) with short oligodeoxyadenylates, is an order of magnitude faster than the formation of DNA triplexes at similar salt concentrations [146]. Also, investigations with DNG (T 5 and T 8 ), show that T m 's are significantly reduced by base pair mismatches [147,148]. This suggest that sequence specific base pairing is the predominant mode of binding between DNG and nucleic acid targets, although it has still to be established whether or not this is accompanied by any non-specific binding, via salt bridges, between the oppositely charged backbones.…”
“…Such studies appear close at hand with the development of an efficient solid phase synthetic method for the synthesis of DNG (Fig. 18) [148]. The synthesis involves the coupling of a 3´-amino nucleoside 58, immobilised on a polystyrene resin, with a 5´-carbodiimide intermediate which is derived from the thiourea 59, upon treatment with HgCl 2 .…”
Nucleic acids have been extensively modified by replacing the phosphodiester group or the whole sugar phosphodiester with alternative anionic, neutral and cationic structures. Several of these modified oligonucleotides exhibit improved properties including enhanced recognition and binding to RNA, duplex DNA and proteins. This has resulted in the development of new and more potent antisense and antigene agents, as well as aptamers. Furthermore, backbone modified oligonucleotides have also been used in the development of several alternative strategies, which rely on altogether different mechanisms of action and show significant promise for therapeutic intervention. In this review the latest advances in the synthesis and evaluation of the most promising backbone modified oligos will be discussed, with a view to their future as novel pharmaceuticals.
“…From the plethora of modifications reported hitherto, oligonucleotides with the amide linkage 385 (Scheme 62) have shown very promising antisense properties by displaying higher binding affinity and very good resistance towards nucleases [339,340]. Oligomers with positively charged guanidine [341][342][343][344][345][346] linker 386 lead in the development of new antisense therapeutics, since the attractive forces between them and the negatively charged DNA or RNA contribute significantly to the stability of heteroduplex and triplex structures formed between these species. In addition, they are stable to enzymatic hydrolysis due to the lack of a phosphodiester linkage.…”
Section: Iv181 Carbohydrate Like Amidoximes With Possible Biologicmentioning
Amidoximes are compounds bearing both a hydroxyimino and an amino group at the same carbon atom which makes them versatile building blocks for the synthesis of various heterocycles. Their importance in chemistry along with their rich biology, make amidoximes an attractive target for medicinal chemists, biochemists and biologists. Amidoximes and simple O-substituted derivatives possess very important biological activities functioning as antituberculotic, antibacterial, bacteriostatic, insecticidal, elminthicidal, antiviral, herbicidal, fungicidal, antineoplastic, antiarrythmic, antihypertensive, antihistaminic, anxiolytic-antidepressant, anti-inflammatory/antioxidant, antiaggregatory (NO donors) or plant growth regulatory agents. A number of amidoximes has already been used as drugs, or currently being in clinical trials. Their numerous pharmaceutical applications have been recently enriched, due to the fact that some mechanistic pathways, concerning their conversion to amidines, as well as their ability to release NO were clarified, giving a new insight to their mode of action and allowing the design of new therapeutic agents. The main subject of the present review paper is to highlight aspects concerning chemical and biological questions on this interesting class of compounds. Some new synthetic methodologies as well as improvements of previously reported general reactions involving amidoximes, acylated amidoximes, and amidines are presented. The biological applications of amidoximes over the end of 2006 are also extensively reviewed.
“…[71Ϫ73] Replacing the phosphate backbone with positively charged guanidinium groups [74] increases the binding of these analogs and makes them resistant to nucleases. [76] Bruice and co-workers have reported the synthesis of deoxynucleotide guanidine oligomers (Scheme 6). [76] Bruice and co-workers have reported the synthesis of deoxynucleotide guanidine oligomers (Scheme 6).…”
Section: Oligonucleotide Analogsmentioning
confidence: 99%
“…[75] The positively charged guanidinium might also give rise to cell membrane permeability by electrostatic attraction of the oligonucleoside to the negatively charged phosphate groups on the cell surface. [76] At first, the resin 6A was loaded with protected and modified nucleotide 6B in the presence of HgCl 2 in DMF to create guanidine 6C. [76] At first, the resin 6A was loaded with protected and modified nucleotide 6B in the presence of HgCl 2 in DMF to create guanidine 6C.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.